Click to download REAKSI September 2015, No.25.

• Hydroxyzine: Risk of Effects on Heart Rhythm
• Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Possible Risk of Diabetic Ketoacidosis

For other issues of REAKSI Drug Safety News, please click here.